Drug Enforcement D-0400-2024

Lack of Assurance of Sterility

Status

Terminated

Classification

Class II

Report Date

April 3, 2024

Termination Date

August 27, 2024

Product Information

Product description
fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.04% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0289-64, Bar Code 70004028964
Product quantity
412 cassettes
Reason for recall
Lack of Assurance of Sterility
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA

Location & Firm

Recalling firm
SCA Pharmaceuticals, LLC
Address
755 Rainbow Rd Ste B, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0400-2024
Event ID
93456
Recall initiation date
November 9, 2023
Center classification date
March 22, 2024
Code info
Lot #: 1223049261, Exp 12/25/23; 1223049724, Exp 01/11/24
More code info